Società Cancer Prevention Pharmaceuticals Inc
Azioni
CPP
US13740W1071
Biotecnologia
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Eugene W. Gerner
FOU | Founder | 76 | 09/06/08 |
Jeffrey Jacob
CEO | Chief Executive Officer | 62 | 09/06/08 |
Alfred M. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jon Saxe
BRD | Director/Board Member | 88 | 23/07/15 |
Richard L. Love
BRD | Director/Board Member | 81 | 01/11/11 |
Jeffrey Jacob
CEO | Chief Executive Officer | 62 | 09/06/08 |
Eugene W. Gerner
FOU | Founder | 76 | 09/06/08 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 6 759 443 | 4 226 504 ( 62,53 %) | 0 | 62,53 % |
Coordinate società
Cancer Prevention Pharmaceuticals, Inc.
1760 East River Road Suite 250
85718, Tucson
+520 908 7774
http://www.canprevent.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+9,58% | 115 Mrd | |
+12,41% | 107 Mrd | |
-12,38% | 22,31 Mrd | |
-3,35% | 21,6 Mrd | |
-3,35% | 18,23 Mrd | |
-38,57% | 17,62 Mrd | |
+7,51% | 14,26 Mrd | |
+35,67% | 12,37 Mrd | |
-24,50% | 8,28 Mrd |